Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Primary Effusion 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Hematologic Diseases 1Graft vs Host Disease 1Congenital Abnormalities 1Blast Crisis 1

Interventions

Cytarabine 28Etoposide 12Daunorubicin 11fludarabine phosphate 10Busulfan 10Peripheral Blood Stem Cell Transplantation 9tipifarnib 8Vorinostat 7Mitoxantrone 7Cyclosporine 7laromustine 6alvocidib 6Filgrastim 6Decitabine 6Cyclophosphamide 6Antilymphocyte Serum 6Idarubicin 5Methotrexate 4Bortezomib 4valspodar 3sargramostim 3romidepsin 3Radiotherapy 3Polymerase Chain Reaction 3Mycophenolic Acid 3Methylprednisolone 3Melphalan 3Gene Expression Profiling 3tanespimycin 2entinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Congenital Abnormalities × Bone Marrow Transplantation × Clear all
NCT00066417 2013-05-01

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
51 enrolled
MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡